Delivery Order SPE2DE24D0013-SPE2D626F8193

Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare operations. This award carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of molecular diagnostic solutions. The contract is performed at Cepheid's Sunnyvale facility and represents part of the company's extensive portfolio of federal diagnostic supply agreements.

Cepheid has established itself as a cornerstone supplier to multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, through its proprietary GeneXpert diagnostic platform and associated testing capabilities. The company maintains two substantial Indefinite Delivery Contracts with the VA valued at approximately $6.7 million and $32.8 million respectively, which serve as the contracting vehicles for ongoing procurement of molecular diagnostic reagents and testing solutions across the VA's distributed network of medical centers through 2030. This delivery order represents continued demand-driven procurement under the Defense Logistics Agency's medical supply distribution framework for critical infectious disease diagnostic capabilities supporting Department of Defense healthcare operations.